News
Novimmune Announces Closing of CHF elEconomista.es
www.eleconomista.es
Feb 18, — Dr. Jonathan Hepple, Partner at Rosetta, has joined Novimmune’s Board of Directors. Dr. Hepple brings more than 15 years’ investment ... › noticias › Novimmune-A...
Aprea AB - Sectoral Asset Management
sectoral.com
Mar 9, — Jonathan Hepple, Ph.D., Partner at Rosetta Capital Ltd. and Board member of Aprea on behalf of KDev Investments AB, said: "We. › PDF › Aprea_news_
Brown Rudnick's Global Life Sciences Group to host event on ...
brownrudnick.com
Nov 12, — Nooman Haque, Silicon Valley Bank; Dr Jonathan Hepple, Rosetta Capital Limited. Following the discussion will be a drink and canapé networking ... › event › brown-rudnicks-gl...
ETH Zurich spin-out Covagen closes CHF6.3M round | Science
sciencebusiness.net
Dec 2, — Jonathan Hepple, Partner at Seroba Kernel, who will join Covagen's board, said the firm believes Fynomer technology, “Can address many of ... › news
sorted by relevance / date